# OnCo record futility (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/futility/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "futility" ;
  schema:name "Futility analysis (stopped for futility)"@en ;
  schema:alternateName "stopped for futility"@en, "stopped early for futility"@en, "futility boundary"@en, "futility analysis"@en, "futility stopping"@en, "discontinued for futility"@en, "terminated for futility"@en, "stopped early for efficacy"@en, "stopped early"@en, "early stopping"@en, "stopping boundary"@en, "data monitoring committee"@en, "DMC"@en, "IDMC"@en, "DSMB"@en, "independent data monitoring committee"@en, "futility boundaries"@en ;
  schema:description "A planned check partway through a trial to see whether the new treatment has any realistic chance of proving better; if not, the trial is stopped to spare patients and money. The opposite rule stops a trial early when benefit is overwhelming."@en ;
  schema:url <https://onco.cc/terms/futility/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Interim_analysis> ;
  schema:citation <https://en.wikipedia.org/wiki/Interim_analysis> ;
  onco:related <https://onco.cc/terms/interim-analysis/>, <https://onco.cc/terms/statistical-significance/>, <https://onco.cc/terms/primary-endpoint/>, <https://onco.cc/terms/accrual/>, <https://onco.cc/terms/data-monitoring-committee/>, <https://onco.cc/terms/group-sequential-design/>, <https://onco.cc/terms/sample-size-re-estimation/>, <https://onco.cc/terms/trial-failure-modes/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:trials <https://onco.cc/trials/javelin-hn-100/>, <https://onco.cc/trials/trilynx/>, <https://onco.cc/trials/magnitude/>, <https://onco.cc/trials/dream3r/> .